Expression of B Cell Receptor-Associated Signaling Molecules in Human Lupus

References

• Reth M., Wienands J. Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol. 1997; 15: 453–79
   PubMed Web of Science ®Google Scholar
• Buhl A., Cambier J. Co-receptor and accessory regulation of B-cell antigen receptor signal transduction. Immunol Rev. 1997; 160: 127–38
   PubMedGoogle Scholar
• Engel P., Zhou L. J., Ord D. C., Sato S., Roller B., Tedder T. F. Abnormal B lymphocyte development, activation. and differentiation in mice that lack or overexpress the CD 19 signal transduction molecule. Immunity. 1995; 3: 39–50
   PubMed Web of Science ®Google Scholar
• Rickert R C., Rajewsky K., Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995; 376: 352–5
   PubMed Web of Science ®Google Scholar
• Sato S., Ono N., Steeber D., Pisetsky D., Tedder T. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-l lineage cells and autoimmunity. J Immunol. 1996; 157: 4371–8
   PubMed Web of Science ®Google Scholar
• Molina H., Holers V. M., Li B., Fung Y., Mariathasan S., Goellner J., Strauss-Schoenbergcr J., Karr R. W., Chaplin D. D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci US A. 1996; 93: 3357–61
   PubMed Web of Science ®Google Scholar
• Kishihara K., Penninger J., Wallace V. A., Kundig T. M., Kawai K., Wakeham A., Timms E., Pfeffer K., Ohashi PS., Thomas M. L., Furlonger C., Paige C. J., Mak T. W. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell. 1993; 74: 143–56
   PubMed Web of Science ®Google Scholar
• Tsitsikov E., Gutierrez-Ramos J., Geha R. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci U S A. 1997; 94: 10844–9
   PubMed Web of Science ®Google Scholar
• Cyster J. G., Healy J. I., Kishihara K., Mak T. W., Thomas M. L., Goodnow C. C. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 1996; 381: 325–8
   PubMedGoogle Scholar
• Hibbs M. L., Tarlinton D. M., Amies J., Grail D., Hodgson G., Maglitto R., Stacker S. A., Dunn A. R. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 1995; 83: 301–11
   PubMed Web of Science ®Google Scholar
• O'Keefe T. L., Williams G. T., Davies S. L., Neuberger M. S. Hyperresponsive B cells in CD22-deficient mice. Science 1996; 274: 798–801
   PubMed Web of Science ®Google Scholar
• Nishizumi H., Taniuchi I., Yamanashi Y., Kitamura D., Ilic D., Mori S., Watanabe T., Yamamoto T. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995; 3: 549–60
   PubMed Web of Science ®Google Scholar
• Sato S., Miller A., Lnaoki M., Bock C., Jansen P., Tang M., Tedder T. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity. 1996; 5: 551–62
   PubMed Web of Science ®Google Scholar
• Nitschke L., Carsetti R., Ocker B., Kohler G., Earners M. CD22 is a negative regulator of B-cell receptor signalling. CurrRiol. 1997; 7: 133–43
   PubMed Web of Science ®Google Scholar
• Otipoby K., Andersson K., Draves K., Klaus S., Farr A., Kerner J., Perlmutter R., Law C., Clark E. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996; 384: 634–7
   PubMed Web of Science ®Google Scholar
• O'Keefe T, Williams G., Batista F., Neuberger M. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med. 1999; 189: 1307–13
   PubMed Web of Science ®Google Scholar
• Kuntz L., Fonteneau P., Loor F. Common and individual features of the humoral immunity dysregulation of mice homozygous at the viable motheaten (mev) mutation. Immunol Letters. 1990; 24: 97–101
   PubMed Web of Science ®Google Scholar
• Shultz L., Schweitzer P., Rajan T., Yi T., Ihle J., Matthews R., Thomas M., Beier D. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 1993; 73: 1445–54
   PubMed Web of Science ®Google Scholar
• Kozlowski M., Mlinaric-Rascan I., Feng G., Shen R., Pawson T., Siminovitch K. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med. 1993; 178: 2157–63
   PubMed Web of Science ®Google Scholar
• Feuerstein N., Chen F., Madaio M., Maldonado M., Eisenberg R. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoprotcins. J Immunol. 1999; 163: 5287–97
   PubMed Web of Science ®Google Scholar
• Liossis S. N., Kovacs B., Dennis G J., Kammer G. M., Tsokos G. C. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest. 1996; 98: 2549–2557
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35: 630–40
   PubMed Web of Science ®Google Scholar
• Zouali M., Madaio M. P., Canoso R. T., Stollar B. D. Restriction fragment length polymorphism analysis of the V kappa locus in human lupus. Eur J Immunol. 1989; 19: 1757–60
   PubMedGoogle Scholar
• Suzuki N., Sakane T. Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus. J Clin Invest. 1989; 83: 937–44
   PubMedGoogle Scholar
• Cyster J., Goodnow C. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity. 1997; 6: 509–17
   PubMed Web of Science ®Google Scholar
• Trowbridge I., Thomas M. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Anna Rev Immunol. 1994; 12: 85–116
   PubMed Web of Science ®Google Scholar
• Cyster J., Goodnow C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity. 1995; 2: 13–24
   PubMed Web of Science ®Google Scholar
• Chan V. W., Meng F., Soriano P., DeFranco A. L., Lowell C. A. Characterization of the B lymphocyte populations in Lyn-defieient mice and the role of Lyn in signal initiation and down-regulation. Immunity. 1997; 7: 69–81
   PubMed Web of Science ®Google Scholar
• Huck S., Zouali M. Expression of the tyrosine kinase Lyn during B-cell receptor engagement and apoptosis. Ann N YAcadScie. 1997; 815: 122–123
   PubMedGoogle Scholar
• Saiki O., Saeki Y., Kishimoto S. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus. J Clin Invest. 1985; 76: 1865–70
   PubMedGoogle Scholar
• Ginsburg W., Finkelman F., Lipsky P. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol. 1979; 35: 76–88
   PubMed Web of Science ®Google Scholar
• DeHoratius R., Messner R. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus. J Clin Invest. 1975; 55: 1254–8
   PubMed Web of Science ®Google Scholar
• Fauci A., Moutsopoulos H. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 1981; 24: 577–83
   PubMedGoogle Scholar
• Reininger L., Winkler T. H., Kalberer C. P., Jourdan M., Melchers F., Rolink A. G. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB × NZW)F1 mice. J Exp Med. 1996; 184: 853–61
   PubMed Web of Science ®Google Scholar
• Kakkanaiah V., Sobel E., MacDonald G., Cheek R., Cohen P., Eisenberg R. B cell genotype determines the fine specificity of autoantibody in Ipr mice. J Immunol. 1997; 159: 1027–35
   PubMedGoogle Scholar
• Radic M. Z., Zouali M. Receptor editing, immune diversification and self-tolerance. Immunity. 1996; 5: 505–511
   PubMedGoogle Scholar
• Lam K., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 1997; 90: 1073–83
   PubMed Web of Science ®Google Scholar
• Delibrias C. C, Floettmann J. E., Rowe M., Fearon D. T. Downregulated Expression Of Shp-1 In Burkitt-Lymphomas and Germinal Center B Lymphocytes. J Exp Med. 1997; 186: 1575–1583
   PubMed Web of Science ®Google Scholar
• Hatta Y., Tsuchiya N., Matsushita M., Shiota M., Hagiwara K., Tokunaga K. Identification of the gene variations in human CD22. Immunogenetics. 1999; 49: 280–286
   PubMed Web of Science ®Google Scholar
• Wang J., Koizumi T., Watanabe T. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in lyn-deficient mice. J Exp Med. 1996; 184: 831–8
   PubMed Web of Science ®Google Scholar
• Chan V., Lowell C., DeFranco A. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr Biol. 1998; 8: 545–53
   PubMedGoogle Scholar
• Smith K., Tarlinton D., Doody G., Hibbs M., Fearon D. Inhibition of the B cell by CD22: a requirement for Lyn. J Exp Med. 1998; 187: 807–11
   PubMedGoogle Scholar
• Nishizumi H., Horikawa K., Mlinaric-Rascan I., Yamamoto T. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J Exp Med. 1998; 187: 1343–8
   PubMed Web of Science ®Google Scholar
• Tsui H., Simuiovitch K., de Souza L., Tsui F. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet. 1993; 4: 124–9
   PubMed Web of Science ®Google Scholar
• Khaled A., Butfiloski E., Villas B., Sobel E., Schiffenbauer J. Aberrant expression of the NF-kappaB and IkappaB proteins in B cells from viable motheaten mice. Autoimmunity 1999; 30: 115–28
   PubMed Web of Science ®Google Scholar
• Schmidt K., Hsu C., Griffin C., Goodnow C., Cyster J. Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. J Exp Med. 1998; 187: 929–37
   PubMedGoogle Scholar
• Cornall R. J., Cyster J. G., Hibbs M. L., Dunn A. R., Otipoby K. L., Clark E. A., Goodnow C. C. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity. 1998; 8: 497–508
   PubMed Web of Science ®Google Scholar
• Pani G., Siminovitch K., Paige C. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J Exp Med. 1997; 186: 581–8
   PubMedGoogle Scholar
• Takeuchi T, Pang M., Amano K., Koike J., Abe T. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1997; 109: 20–26
   PubMed Web of Science ®Google Scholar
• Takeuchi T., Tsuzaka K., Pang M., Amano K., Koide J., Abe T. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus. Int Immunol. 1998; 10: 911–921
   PubMed Web of Science ®Google Scholar
• Mimura T., Fernstern P., Jarjour W., Winfield J. Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus. J Exp Med. 1990; 172: 653–656
   PubMed Web of Science ®Google Scholar
• Mittler R., Greenfield R., Schacter B., Richard N., Hoffmann M. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells. J Immunol. 1987; 138: 3159–66
   PubMedGoogle Scholar
• Neumeister Kersh E., Shaw A., Allen P. Fidelity of T Cell Activation Through Multistep T Cell Receptor Phosphorylation. Science 1998; 281: 572–575
   PubMedGoogle Scholar
• Huck S., Zouali M. DNA methylation: a potential pathway to abnormal autoreative lupus B cells. Clin Immunol Immunopalhol. 1996; 80: 1–8
   PubMedGoogle Scholar
• Botto M., Dell'Agnola C., Bygrave A. E., Thompson E. M., Cook H. T., Petry F., Loos M., Pandolfi P. P., Walport M J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998; 19: 56–59
   PubMed Web of Science ®Google Scholar
• Huck S., Deveau E., Namane A., Zouali M. Abnormal DNA Methylation and Deoxycytosine-Deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis. FASEB J. 1999; 13: 1415–1422
   PubMed Web of Science ®Google Scholar